Stock Option Trading News

Analyzing the Analysts – Buy, Hold Or Sell

The terminology used by stock market research analysts is anything but uniform, many of the analysts use the conventional terms “buy”, “hold” and “sell” for making their stock market research recommendations, which makes sense, as that’s what investors do, buy, hold and sell for their personal stock portfolio.

However, there are a plethora of terms used by analysts having unclear meanings, for example a popular recommendation is “accumulate”. A lot of the stuff I purchase “accumulates”, and a lot of it ends up in the garage or the basement, so how does a person go about “accumulating” a stock, buy a little here, and a little there? Another term the analysts like to use is “strong buy”. So how does a person execute a “strong buy”? There must be a special button on the broker’s web site for executing a “strong buy”, but I’ve never seen it. “Market outperform”, “market perform”, and “market underperform” are some other analyst terminology. Does this mean we’re supposed to watch it “perform”, are we supposed to clap, exactly what are we supposed to do with this information?

A term I really like is “neutral”, when an analyst says he’s neutral, what does that mean? When my car’s in neutral it doesn’t go anywhere, I want to own stocks that are going to go up, not be parked in neutral. And then there are the eating disorder recommendations, “overweight”, “equal-weight” and “underweight”. Does overweight mean to buy the stock, or does the term imply we should gorge on the stock? There are many other terms which are equally confusing: “trading buy”, “trading sell”, “in-line”, “positive”, “negative”, “under review”, “peer perform”, “long-term buy”, “speculative investment”, and “sector perform”. What should we do with all of this information?

We’ve analyzed the record of the stock research analysts going back to February 1998 for all current stocks listed on the Nasdaq, NYSE and American stock exchanges. Stocks for companies going belly up or delisted are not included as are companies that have been acquired by or merged with other companies, and analysts without a recommendation issued in 2006 were also not considered. For this analysis, we assumed “market outperform” means a buy, “market underperform” means the stock is to be sold, etc.

Another issue we must take into consideration is that analysts sometimes recommend a stock for a buy, and then cease to cover the stock, but never issue a sell recommendation, for this case we just assumed we’re supposed to continue holding the stock. This behavior seems a little inconsiderate, as the analyst convinces a person to purchase a position, then just leaves them there holding the stock without any recommendation as to what they are supposed to do with it.

The results of our analysis are show below:

Analyst Start
Date
End
Date
Best
Pick
Best
Pick
%
Ret
Worst
Pick
Worst
Pick
%
Ret
# Co’s
Cvrd
%
Right
Avg
%
Ret
S&P 500
% Ret
%
Ret
Over
S&P 500
AG
Edwards
Mar98 May06 PMK 1696% ANLT -100% 694 68% 51% 22% 29%
Adam
Harkness
Mar98 Jan06 CTSH 4825% EMRG -100% 331 45% 32% 17% 15%
Am
Tech/JSA
Research
May05 May06 AMKR 102% CNCT -34% 48 56% 5% 7% -2%
Avondale
Partners
Aug03 May06 PSYS 394% TRMM -68% 81 65% 27% 31% -4%
B.
Riley
Apr02 Apr06 CRDN 1155% OLGC -64% 51 59% 52% 19% 33%
BB&T
Capital
Mkts
Mar00 Jun06 PPDI 799% VERT -100% 269 72% 55% -14% 69%
Banc of
America Sec
May99 May06 FRO 2281% ICGE -100% 993 61% 39% -1% 40%
Barrington
Research
Jul99 May06 IBKC 362% PRGX -94% 90 67% 31% -5% 36%
Bear
Stearns
Mar98 Jun06 GIL 2365% GOAM -100% 751 61% 57% 17% 40%
Bernstein Aug01 Apr06 GLW 363% PIR -57% 96 74% 44% 5% 39%
Brean
Murray
Aug98 Jun06 ASFI 410% AKSY -87% 161 48% 13% 17% -4%
CE
Unterberg
Towbin
Oct98 May06 CNQR 738% GOAM -100% 247 38% 4% 23% -19%
CIBC
World
Market
May99 Jun06 VTR 1516% RBAK -100% 806 56% 43% 0% 43%
CL
King
Dec04 Jun06 AFCE 171% PQE -67% 46 65% 15% 7% 8%
Credit
Suisse
Feb98 May06 PR 6144% VERT -100% 1238 64% 64% 23% 41%
Calyon
Securities
Mar05 May06 DNR 114% FRNT -32% 58 67% 12% 9% 3%
Caris
and Co.
Jun03 Jun06 CELG 420% GENR -81% 160 50% 8% 27% -19%
Citigroup Aug05 May06 HANS 216% IDIX -56% 196 62% 8% 3% 5%
Cowen
and Co
Mar98 Jun06 PPDI 534% ARDM -98% 32 50% 40% 23% 17%
DA
Davidson
Aug98 Jun06 AMIE 613% PLB -89% 144 72% 44% 20% 24%
Deutsche
Securities
Jul98 Jun06 MDR 660% DRL -83% 605 68% 37% 10% 27%
Dougherty
and Co.
Feb01 May06 TASR 582% ISIG -84% 79 58% 35% 2% 33%
FTN
Midwest
Oct03 Jun06 GPN 114% ALGN -60% 76 66% 11% 23% -12%
Ferris
Baker
Nov98 May06 DECK 684% VYYO -89% 185 67% 36% 13% 23%
First
Albany
Feb02 Jun06 SWN 918% ATAR -85% 341 56% 30% 16% 14%
First
Analysis
Sec.
Sep99 Jun06 TTI 1716% ARBA -99% 61 49% 53% -2% 55%
Friedman
Billings
Apr98 May06 NEU 7053% ITWO -98% 519 65% 67% 16% 51%
Global
Crown
Capital
Aug05 Jun06 NVDA 44% CMOS -50% 20 55% 4% 5% -1%
Goldman
Sachs
Feb98 Jun06 NEU 1306% ICGE -100% 886 66% 56% 25% 31%
HSBC
Securities
Apr98 May06 BRG 264% FTE -69% 39 62% 32% 18% 14%
Harris
Nesbitt
Jul03 Jun06 TXU 349% PARS -87% 138 62% 12% 30% -18%
Hibernia
Southcoast
Capital
Oct04 Apr06 DO 144% DRL -72% 61 75% 27% 16% 11%
Hilliard
Lyons
Apr98 May06 TOFC 24% LANV -16% 24 67% 4% 14% -10%
Investec Jun02 Jan06 LIFC 1454% ESST -85% 38 71% 112% 25% 87%
J.P.
Morgan
Mar98 Jun06 NEU 3555% ICGE -100% 1063 67% 47% 20% 27%
JMP
Securities
Jul02 Jun06 UPFC 351% GNTA -87% 260 59% 22% 36% -14%
Janco
Partners
Oct04 Jun06 BWNG 141% COOL -85% 30 47% 3% 13% -10%
Janney
Montgomery
Feb99 May06 URBN 931% VERT -100% 204 66% 48% 5% 43%
Jefferies Apr98 Jun06 XLG 1838% RBAK -100% 650 65% 51% 17% 34%
Kaufman
Bros.
Feb99 Jun06 GYI 6444% FTGX -100% 162 43% 54% 1% 53%
Keefe
Bruyette
Mar98 Jun06 NEU 1495% PXT -84% 139 79% 44% 21% 23%
KeyBanc
Capital Mkts/
McDonald
Apr04 May06 ISRG 603% JAS -56% 213 71% 25% 13% 12%
Ladenburg
Thalman
Oct98 May06 ASCA 1335% VLTS -97% 97 46% 36% 21% 15%
Lazard
Captial
Nov05 May06 NTRI 43% WRNC -31% 22 45% -3% 6% -9%
Leerink
Swann
Jul03 May06 ILMN 139% DYAX -72% 51 43% 3% 30% -27%
Lehman
Brothers
Feb98 May06 FRO 2281% ICGE -100% 1153 65% 49% 23% 26%
Longbow Aug04 May06 TIE 402% PLAY -56% 41 78% 44% 19% 25%
Matrix
Research
Jan06 Jun06 IACI 371% PLAY -55% 129 44% 1% 1% 0%
Merrill
Lynch
Feb98 Apr06 SID 2302% VERT -100% 1187 65% 70% 25% 45%
Merriman
Curhan
Ford
Oct03 Jun06 AGN 462% SQNM -83% 166 46% 9% 23% -14%
Miller
Johnson
Jan04 Jun06 SMSI 190% CRAY -74% 32 50% 22% 12% 10%
Moors
and
Cabot
Sep03 Feb06 LSI 86% ASYT -77% 65 60% 6% 25% -19%
Morgan
Joseph
Jan05 Jun06 ADTN 594% XMSR -58% 49 55% 25% 8% 17%
Morgan
Keegan
May98 May06 QSII 1532% PRW -95% 204 66% 73% 17% 56%
Morgan
Stanley
Mar98 Jun06 FRO 2281% GOAM -100% 1090 65% 49% 23% 26%
Needham Nov98 May06 HOLX 586% ITWO -99% 420 49% 19% 13% 6%
Nollenberger
Capital
Oct05 Apr06 SHFL 56% PALM -28% 24 54% 4% 9% -5%
Oppenheimer Sep03 May06 TSO 384% VION -65% 212 56% 9% 26% -17%
Pacific
Crest
Mar99 May06 WFMI 588% VERT -100% 118 46% 21% 0% 21%
Pacific
Growth
Equities
Dec99 Jun06 CWTR 1030% ITWO -99% 235 50% 26% -10% 36%
Piper
Jaffray
Feb98 May06 STRL 6132% PRGX -98% 412 58% 42% 24% 18%
Prudential Feb98 Jun06 COH 927% ARBA -99% 762 65% 58% 23% 35%
Punk
Ziegel
Jul98 May06 CCI 696% CTIC -91% 62 50% 35% 14% 21%
RBC
Capital
Mkts
Nov01 Jun06 CWTR 851% UPCS -93% 438 70% 39% 15% 24%
Robert
W.
Baird
Dec99 May06 WCC 636% VERT -100% 484 65% 31% -10% 41%
Rodman
and
Renshaw
Sep02 May06 JCOM 307% ALT -95% 82 41% 0% 58% -58%
Roth
Capital
Mar00 Jun06 UHAL 1489% MBAY -99% 192 57% 47% -12% 59%
Ryan Beck
and Co
Oct02 May06 ADSK 480% ALT -96% 136 69% 30% 66% -36%
Sanders
Morris
Harris
Mar03 May06 VLO 550% CPWM -63% 87 69% 50% 49% 1%
Sandler
O’Neill
Nov04 May06 NDAQ 172% NPTE -24% 82 83% 16% 9% 7%
Soleil Dec05 May06 SPTN 30% WIND -38% 45 49% -2% 1% -3%
Southwest
Sec
Jan99 Jan06 PNRA 1146% ARTG -95% 120 53% 49% 15% 34%
Stanford Nov04 Jun06 BMRN 153% SGTL -81% 119 67% 13% 10% 3%
Stephens
Inc.
Mar98 May06 SWN 1420% ARBA -99% 212 66% 66% 20% 46%
Stifel
Nicolaus
Mar00 May06 BTU 966% ELOY -92% 183 66% 41% -14% 55%
Susquehanna
Financial
Nov04 May06 CHH 117% INCY -39% 104 48% 6% 10% -4%
ThinkEquity Apr03 May06 DNA 365% BPUR -95% 106 53% 14% 45% -31%
Thomas
Weisel
Jun99 Jun06 CHS 668% RBAK -100% 492 51% 9% -4% 13%
UBS Jun03 Jun06 ARNA 702% DCN -96% 537 66% 23% 29% -6%
WR
Hambrecht
Feb00 May06 MRVL 468% RBAK -100% 276 50% 20% -9% 29%
Wachovia Apr00 May06 URBN 1016% VITR -96% 501 65% 31% -12% 43%
Wedbush
Morgan
Sep99 May06 URBN 466% DLK -99% 196 56% 20% -4% 24%
William
Blair
Jul99 May06 JLL 590% JDSU -96% 234 56% 20% -3% 23%

According to this analysis (only currently available stocks on Nasdaq, NYSE and American), 70% of the analysts outperformed the S&P500 Index (SPX) over the time period of coverage, the recommendation with the largest return was Friedman Billings recommendation of NewMarket Corp (NEU <> 7053%), the analyst with the best average return (112%) and the best performance compared to the S&P500 (excess return 87%) was Investec, and the analyst with the best success rate was Sandler O’Neil (83%). Lazard Capital generated the worst average return (-3%) (Note: Lazard Capital’s time of coverage is very short), Rodman and Renshaw turned in the worst performance compared to the S&P500 Index (-58%) and CE Unterberg Towbin exhibited the worst success rate (38%).

Interestingly, almost all of the analysts recommended “dogs with fleas”, the average of the worst pick returns was -82% and the average analyst success rate was 60%, so unless the analyst has a few home runs to make up for the “dogs with fleas”, their results generally aren’t very good.

At PowerOptions, our patented search tools were developed to aid customers in generating consistent income with smaller wins, but also with fewer and smaller “dogs with fleas”.

[tags]stock market research, personal stock portfolio, stock research[/tags]

Leave a Reply

Your email address will not be published. Required fields are marked *